The Role of New Agents in the Treatment of Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|66|1|1-17

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.1, 2004-03, pp. : 1-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer

By  

Oncology, Vol. 83, Iss. 2, 2012-07 ,pp. : 108-116

Karger

Access to resources Recommend Favorite

Personalized Treatment of Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Iron Chelation in the Treatment of Cancer: A New Role for Deferasirox?

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 53, Iss. 9, 2013-09 ,pp. : 885-891

John Wiley & Sons Inc

Access to resources Recommend Favorite

Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents

By DaCosta Byfield Stacey  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 1071-1081

Informa Healthcare

Access to resources Recommend Favorite

New Agents in Advanced Non-Small-Cell Lung Cancer Treatment

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 103-112

Karger

Access to resources Recommend Favorite